CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.24	9	7.79	4.09	6.67
Short-Term Investments	12.63	29.92	-	-	-
Cash & Short-Term Investments	20.86	38.92	7.79	4.09	6.67
Cash Growth	-46.39%	399.46%	90.37%	-38.59%	-
Accounts Receivable	0.43	2.25	0.92	-	-
Other Receivables	-	-	-	-	0.07
Receivables	0.43	2.25	0.92	-	0.07
Prepaid Expenses	1.27	1.91	1.26	0.06	0.02
Other Current Assets	0.32	-	-	-	0.05
Total Current Assets	22.88	43.08	9.96	4.16	6.82
Other Long-Term Assets	-	-	0.01	-	-
Total Assets	22.88	43.08	9.97	4.16	6.82
Accounts Payable	1.45	1.51	0.66	0.1	0.02
Accrued Expenses	3.12	2.25	1.84	0.59	0.4
Current Portion of Long-Term Debt	-	-	-	12.41	4.11
Other Current Liabilities	0.08	0.12	0.09	0.05	0.03
Total Current Liabilities	4.66	3.88	2.6	13.16	4.56
Long-Term Debt	-	-	-	-	5.92
Total Liabilities	4.66	3.88	2.6	13.16	10.47
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-In Capital	115.91	109.87	61.81	18.98	18.52
Retained Earnings	-97.7	-70.73	-54.44	-52.27	-46.47
Comprehensive Income & Other	0.01	0.06	-	-	-
Total Common Equity	18.22	39.2	7.38	-33.29	-27.94
Shareholders' Equity	18.22	39.2	7.38	-9	-3.66
Total Liabilities & Equity	22.88	43.08	9.97	4.16	6.82
Total Debt	-	-	-	12.41	10.03
Net Cash (Debt)	20.86	38.92	7.79	-8.32	-3.36
Net Cash Growth	-46.39%	399.46%	-	-	-
Net Cash Per Share	2.31	4.82	2.93	-16.06	-0.75
Filing Date Shares Outstanding	9.26	8.7	6.17	4.5	4.5
Total Common Shares Outstanding	9.25	8.7	5.67	4.5	4.5
Working Capital	18.22	39.2	7.37	-9	2.26
Book Value Per Share	1.97	4.50	1.30	-7.39	-6.21
Tangible Book Value	18.22	39.2	7.38	-33.29	-27.94
Tangible Book Value Per Share	1.97	4.50	1.30	-7.39	-6.21

Source: S&P Capital IQ. Standard template. Financial Sources.